Autoimmune: Page 4

Qiagen marks milestone for TB blood test

By LabPulse.com staff writers

The fourth-generation QuantiFeronTB Gold Plus assay is being used to test patients in over 130 countries, the company said. It identifies interferon-gamma released by T cells after recognizing TB-specific antigens as a marker of TB infection.

March 23, 2022

'Rogue antibodies' hint at severe COVID risk

By Leah Sherwood

The goal of the study was to identify circulating factors, such as hormones and antibodies, in COVID-19 patients that contribute to the activation and dysfunction of endothelial cells, which are the main type of cell found in the inside lining of blood vessels, lymph vessels, and the heart.

February 16, 2022

Agilent acquires Virtual Control's lab AI technology

By LabPulse.com staff writers

Specifically, ACIES will be used with liquid chromatography/mass spectrometry (LC/MS) and gas chromatography and MS (GS/MS) instruments. It automates the labor-intensive task of GS/MS data analysis, improving efficiency in the laboratory workflow from sampling to reporting, Agilent said.

February 16, 2022

Siemens launches ELF test in the U.S. for NASH assessment

By LabPulse.com staff writers

The ELF test is ordered by a physician and generates a numeric score that has been proven to assess prognosis in patients with advanced fibrosis (F3 or F4) due to NASH. The test is now commercially available after receiving de novo marketing authorization from the U.S. Food and Drug Administration (FDA) in August 2021.

January 25, 2022

Hologic adds SARS-CoV-2 test to global testing project

By LabPulse.com staff writers

Hologic launched GAI at the 2018 International AIDS Conference as an initiative to offer an all-inclusive pricing structure with no upfront cost or capital expenditure. In addition to the SARS-CoV-2 assay, the company offers other tests in the initiative, including tests for HIV-1, hepatitis B and C, and HPV.

January 4, 2022

AMP 2021 meeting puts spotlight back on cancer

By Bruce Carlson

Seminars at AMP 2021 focused on technologies and techniques to help detect and profile tumors, with special emphasis on hard-to-detect cancer cells that remain in patients after treatment.

November 22, 2021

Whole-genome sequencing aids diagnosis of rare diseases

By Rebekah Moan

In a pilot study, the genes of nearly 5,000 people with rare, undiagnosed diseases were analyzed by researchers from Genomics England and Queen Mary University of London partnered with the National Institute for Health Research BioResource. The group claimed the project was the first to analyze the diagnostic and clinical effect of whole-genome sequencing for a wide range of rare diseases within a national healthcare system -- in this instance, the U.K. National Health Service (NHS).

November 10, 2021

Thermo Fisher touts product launches at AACC 2021

By LabPulse.com staff writers

For COVID-19, there are two polymerase chain reaction (PCR) tests: the Applied Biosystems TaqPath COVID-19 Fast PCR Combo Kit 2.0 and the Applied Biosystems TaqPath COVID-19 RNase P Combo Kit 2.0. The tests target eight genes across three regions of SARS-CoV-2.

September 28, 2021

FDA clears Thermo Fisher's new blood test for lupus

By LabPulse.com staff writers

The EliA SmDP-S Test is designed to reduce the number of false-positive results and provide improved diagnostic guidance for SLE. The new test enhances specificity without sacrificing sensitivity, Thermo Fisher said.

August 25, 2021

Siemens gets FDA nod for ELF test for liver fibrosis

By LabPulse.com staff writers

ELF is a noninvasive blood test intended for use with the company's Advia Centaur XP immunoassay system. The test provides a numeric score that is automatically generated via an algorithm and is used to assess the likelihood of progressing to cirrhosis and liver-related clinical events in patients with severe or advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH).

August 23, 2021

Ortho launches IL-6 reagent pack

By LabPulse.com staff writers

Conditions that can be targeted by the test include autoimmune disorders, sepsis, severe respiratory infections from COVID-19, and community-acquired pneumonia in critically ill patients.

July 22, 2021

Inova's Aptiva autoimmune disease assay gets FDA nod

By LabPulse.com staff writers

The company's Aptiva system and Aptiva Celiac Disease Immunoglobulin A (IgA) assay are based on Inova's particle-based multianalyte technology (PMAT). This technology allows Aptiva to deliver up to 720 results per hour using a 12-analyte test cartridge, allowing a laboratory to complete its workflow in a single shift, according to the San Diego-based company.

June 29, 2021

Previous Page

Page 4 of 9

Next Page